Long Term Progression Free Survival Achieved by Maintenance “Second–Line” Polychemotherapy With Gemcitabine/Paclitaxel in Metastatic Urothelial Cancer of the Renal Pelvis—A Case Report

Journal of Cancer Therapy
doi 10.4236/jct.2010.14035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy
2013English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

Front-Line Treatment With Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results From a Phase II Study

Urology
Urology
2016English

Extended Progression-Free Survival of Renal Cell Carcinoma With Axitinib: Case Report

Journal of Urology and Renal Diseases
2018English

Long-Term Survival in a Case of Renal Cell Carcinoma With Brain Metastases: A Case Report

Clinical Medicine Insights: Case Reports
Medicine
2019English

Long-Term Survival in a Patient With Metastatic Squamous Cell Lung Carcinoma: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Long-Term Progression-Free Survival of Third-Line Apatinib in Lung Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

Clinical Cancer Research
Cancer ResearchOncology
2010English

Long‑term Survival in a Recipient of Kidney Transplant Without Maintenance Immunosuppression: A Case Report

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy